Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: This study investigated the effects of a marine oil extract (PCSO-524®) on inattention, hyperactivity, mood and cognition in children and adolescents. PCSO-524® is a standardised lipid extract of the New Zealand green-lipped mussel and is an inflammatory modulator that inhibits the 5'-lipoxygenase and cyclooxygenase pathways and decreases concentrations of the pro-inflammatory arachidonic acid (AA). METHODS: PCSO-524® or a matched placebo was administered for 14 weeks to 144 participants (123 males/21 females; mean age 8.7 years) with high hyperactivity and inattention in a randomised, double-blind, placebo-controlled study. The primary outcome was the Conners Parent Rating Scale assessing parental reports of behavioural problems. Secondary outcomes assessed changes in cognition and mood. RESULTS: The results of the present study did not support the hypothesis that PCSO-524® improves parental reports of hyperactivity, inattention and impulsivity in children ages 6 to 14 years over placebo. Repeated measures ANOVA on post hoc subsample analysis indicated significant improvements in hyperactivity (p = 0.04), attention (p = 0.02), learning (p = 0.05) and probability of ADHD (p = 0.04) with a medium to large average effect size (d = 0.65) in those children who did not meet criteria for combined hyperactivity and inattention. Furthermore, significant improvements in the PCSO-524® group were indicated in a whole sample repeated measures ANCOVA on recognition memory between baseline and week 8 over placebo (p = 0.02, d = 0.56); this difference was not sustained at week 14. CONCLUSIONS: The results presented indicate that PCSO-524® may be beneficial in reducing levels of hyperactivity and inattention in a population of children with clinical and subclinical symptoms of ADHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Complementary and alternative medicines (CAM) are fast becoming viable standalone or adjunctive treatment preferences in place of pharmaceutical treatment for a range of developmental disorders including attention-deficit/hyperactivity disorder (ADHD) [5,28,38], mental retardation [31,39], autism spectrum disorders [40], and learning disorders [41,42].”
From Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents (2017) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )
Segal, D. L. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,666
(2001) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2001.tb01222.x · Cited by 3,461
The clinical global impressions scale: applying a research tool in clinical practice.
Busner, J., & Targum, S. D. (2007) · PubMed Central · Cited by 2,806
Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects
(2014) · Jahrbuch für Wissenschaft und Ethik · doi:10.1515/jwiet-2014-0117 · Cited by 2,473
(1998) · Cited by 2,026
Conners, C. K., Sitarenios, G., Parker, J. D. A., & Epstein, J. N. (1998) · Journal of Abnormal Child Psychology · doi:10.1023/a:1022602400621 · Cited by 1,772 · cited 3×
“The primary outcome was the Conners Parent Rating Scales (CPRS), a comprehensive checklist for acquiring parental reports of the behavioural problems that presented, which was completed every 4 weeks (Conners et al. 1998).”
BackgroundMethodInfluentialAttention-Deficit/Hyperactivity Disorder: A Selective Overview
Biederman, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,351 · cited 1×
“Attention-deficit/hyperactivity disorder (ADHD) is the most prevalent developmental disorder in school-aged children, with ADHD’s prevalence being estimated withinWestern cultures to be between 5 and 12% (Biederman 2005; Wolraich et al. 2005).”
BackgroundSonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070991 · Cited by 1,167 · cited 1×
“Nevertheless, it should be noted that two recent meta-analyses have suggested positive but small effect sizes for LC PUFAs and behavioural symptoms with children and adolescents with ADHD (Sonuga-Barke et al. 2013; Bloch and Qawasmi 2011).”
ResultDeclaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects
World Medical Association (WMA) (2009) · Jahrbuch für Wissenschaft und Ethik · doi:10.1515/9783110208856.233 · Cited by 1,087
Journal of the Pakistan Medical Association
(2020) · Journal of the Pakistan Medical Association · doi:10.5455/jpma · Cited by 1,047
Cited by
Martinat, M., Rossitto, M., Miceli, M. D., & Layé, S. (2021) · Nutrients · doi:10.3390/nu13041185 · Cited by 161
Healy-Stoffel, M., & Levant, B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180412153612 · Cited by 133
Agostoni, C., Nobile, M., Ciappolino, V., Delvecchio, G., Tesei, A., Turolo, S., Crippa, A., Mazzocchi, A., Altamura, C., & Brambilla, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122608 · Cited by 125
“Concerning neuropsychological functioning, three RCTs using higher doses of EPA than DHA [82,86,87] found a treatment effect on visual sustained attention performance, delayed memory and working memory function.”
BackgroundMallick, R., Basak, S., & Duttaroy, A. K. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101116 · Cited by 135
Basak, S., Mallick, R., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2021) · Nutrients · doi:10.3390/nu13062061 · Cited by 104
“strated significant improvement in ADHD symptoms[124,208-219].”
Metadata
- Authors
- Kean, J. D., Sarris, J., Scholey, A., Silberstein, R., Downey, L. A., & Stough, C.
- Affiliations
- Swinburne University of Technology (AU)
- The University of Melbourne (AU)
- Corresponding author
- Stough, Con
- Venue
- Psychopharmacology
- Published
- 2016-12-05
- Volume
- 234
- Issue
- 3
- Pages
- 403-420
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC5225177
- OpenAlex
- W2560670432
- Cited by
- 32
- References
- 61
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 3
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion, cc-by)
- Swinburne figshare (Swinburne University of Technology) (cc-by)
- Funders
- Pharmalink
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Keywords
- attention deficit hyperactivity disorder, hyperactivity, inattention, children and adolescents, green-lipped mussel, lipid extracts, 5-lipoxygenase inhibition, cyclooxygenase inhibition, arachidonic acid, inflammation, cognition, recognition memory, mood, dietary supplementation
- MeSH terms
- Olive Oil, Adolescent, Affect, Attention, Attention Deficit Disorder with Hyperactivity, Child, Cognition, Double-Blind Method, Female, Humans, Lipids, Male, Vitamin E, Vitamins, Fatty Acids, Omega-3, Treatment Outcome, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1007/s00213-016-4471-y
- The paper
- Kean, J. D., Sarris, J., Scholey, A., Silberstein, R., Downey, L. A., & Stough, C. (2017). Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial. Psychopharmacology. https://doi.org/10.1007/s00213-016-4471-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.